<DOC>
	<DOC>NCT01213121</DOC>
	<brief_summary>- To examine differences in neurophysiologic parameters between unmedicated patients with bipolar depression and healthy controls - To examine within-subject changes in neurophysiologic parameters in patients with bipolar depression treated with quetiapine</brief_summary>
	<brief_title>Neurophysiologic Changes in Patients With Bipolar Depression</brief_title>
	<detailed_description>- Alterations of neurophysiologic regulation has been suggested in patients with major depressive disorder or bipolar disorders - Depressive phase of bipolar disorder shows multi-faceted characteristics different from unipolar depression - Quetiapine is an atypical antipsychotic licensed for treatment of bipolar depression - The aim of this study is to investigate the pattern of neurophysiologic dysregulation in bipolar depression and its changes induced by quetiapine treatment</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>DSMIV bipolar disorder I or II Depressive phase Drugnaive or drugfree Serious medical or neurological conditions DSMIV substancerelated disorders (within 12 months prior to participation) Mentally retarded</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>bipolar depression</keyword>
	<keyword>heart rate variability</keyword>
	<keyword>cardio-respiratory coupling</keyword>
	<keyword>electroencephalography</keyword>
</DOC>